Strategies for advancing cancer nanomedicine

Vikash P. Chauhan; Rakesh K. Jain

doi:10.1038/nmat3792

journal article·2013-11Open access

Strategies for advancing cancer nanomedicine

Vikash P. Chauhan, Rakesh K. Jain

Nature Materials· Volume 12· Issue 11

Publisher page Open full text

Source abstract

Abstract

Cancer nanomedicines approved so far minimize toxicity, but their efficacy is often limited by physiological barriers posed by the tumour microenvironment. Here, we discuss how these barriers can be overcome through innovative nanomedicine design and through creative manipulation of the tumour microenvironment.

Source: openaire · Quality: candidate unverified · Source record ↗

Research context

Nanomaterials

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (83)

Show source-provided references

1. Gerlowski, L. E. & Jain, R. K. Microvasc. Res. 31, 288–305 (1986).10.1016/0026-2862(86)90018-X ↗

2. Matsumura, Y. & Maeda, H. Cancer Res. 46, 6387–6392 (1986).

3. Jain, R. K. J. Clin. Oncol. 31, 2205–2218 (2013).10.1200/JCO.2012.46.3653 ↗

4. Dvorak, H. F., Brown, L. F., Detmar, M. & Dvorak, A. M. Am. J. Pathol. 146, 1029–1039 (1995).

5. Carmeliet, P. & Jain, R. K. Nature 473, 298–307 (2011).10.1038/nature10144 ↗

6. Jain, R. K. Science 307, 58–62 (2005).10.1126/science.1104819 ↗

7. Hashizume, H. et al. Am. J. Pathol. 156, 1363–1380 (2000).10.1016/S0002-9440(10)65006-7 ↗

8. Hobbs, S. K. et al. Proc. Natl Acad. Sci. USA 95, 4607–4612 (1998).10.1073/pnas.95.8.4607 ↗

9. Leu, A. J., Berk, D. A., Lymboussaki, A., Alitalo, K. & Jain, R. K. Cancer Res. 60, 4324–4327 (2000).

10. Padera, T. P. et al. Nature 427, 695 (2004).10.1038/427695a ↗

11. Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J. & Jain, R. K. Nature Biotechnol. 15, 778–783 (1997).10.1038/nbt0897-778 ↗

12. Stylianopoulos, T. et al. Proc. Natl Acad. Sci. USA 109, 15101–15108 (2012).10.1073/pnas.1213353109 ↗

13. Padera, T. P. et al. Science 296, 1883–1886 (2002).10.1126/science.1071420 ↗

14. Peer, D. et al. Nature Nanotech. 2, 751–760 (2007).10.1038/nnano.2007.387 ↗

15. Goel, S. et al. Physiol. Rev. 91, 1071–1121 (2011).10.1152/physrev.00038.2010 ↗

16. Jain, R. K. & Stylianopoulos, T. Nature Rev. Clin. Oncol. 7, 653–664 (2010).10.1038/nrclinonc.2010.139 ↗

17. Chauhan, V. P., Stylianopoulos, T., Boucher, Y. & Jain, R. K. Annu. Rev. Chem. Biomolecular Eng. 2, 281–298 (2011).10.1146/annurev-chembioeng-061010-114300 ↗

18. Jain, R. K. Cancer Res. 47, 3039–3051 (1987).

19. Jain, R. K. Cancer Metast. Rev. 6, 559–593 (1987).10.1007/BF00047468 ↗

20. Aird, W. C. Circ. Res. 100, 158–173 (2007).10.1161/01.RES.0000255691.76142.4a ↗

21. Sarin, H. J. Angiogenes. Res. 2, 14 (2010).10.1186/2040-2384-2-14 ↗

22. Yuan, F. et al. Cancer Res. 55, 3752–3756 (1995).

23. Yuan, F. et al. Cancer Res. 54, 3352–3356 (1994).

24. Chauhan, V. P. et al. Nature Nanotech. 7, 383–388 (2012).10.1038/nnano.2012.45 ↗

25. Cabral, H. et al. Nature Nanotech. 6, 815–823 (2011).10.1038/nnano.2011.166 ↗

26. Jacobetz, M. A. et al. Gut 62, 112–120 (2013).10.1136/gutjnl-2012-302529 ↗

27. Pluen, A., Netti, P. A., Jain, R. K. & Berk, D. A. Biophys. J. 77, 542–552 (1999).10.1016/S0006-3495(99)76911-0 ↗

28. Stylianopoulos, T. et al. Biophys. J. 99, 1342–1349 (2010).10.1016/j.bpj.2010.06.016 ↗

29. Dreher, M. R. et al. J. Natl Cancer I 98, 335–344 (2006).10.1093/jnci/djj070 ↗

30. Mayer, L. D. et al. Cancer Res. 49, 5922–5930 (1989).

31. Zou, Y. Y., Ling, Y. H., Reddy, S., Priebe, W. & Perezsoler, R. Int. J. Cancer 61, 666–671 (1995).10.1002/ijc.2910610513 ↗

32. Choi, H. S. et al. Nature Nanotech. 5, 42–47 (2010).10.1038/nnano.2009.314 ↗

33. Choi, H. S. et al. Nature Biotechnol. 25, 1165–1170 (2007).10.1038/nbt1340 ↗

34. Mitragotri, S. & Lahann, J. Nature Mater. 8, 15–23 (2009).10.1038/nmat2344 ↗

35. Champion, J., Walker, A. & Mitragotri, S. Pharm. Res. 25, 1815–1821 (2008).10.1007/s11095-008-9562-y ↗

36. Chithrani, B. D., Ghazani, A. A. & Chan, W. C. W. Nano Lett. 6, 662–668 (2006).10.1021/nl052396o ↗

37. Chauhan, V. P. et al. Angew. Chem. Int. Ed. 50, 11417–11420 (2011).10.1002/anie.201104449 ↗

38. Park, J. H. et al. Adv. Mater. 20, 1630–1635 (2008).10.1002/adma.200800004 ↗

39. Chu, K. S. et al. Nanomedicine: Nanotechnol. Biol. Med. 9, 686–693 (2013).10.1016/j.nano.2012.11.008 ↗

40. Smith, B. R. et al. Nano Lett. 12, 3369–3377 (2012).10.1021/nl204175t ↗

41. Ruggiero, A. et al. Proc. Natl Acad. Sci. USA 107, 12369–12374 (2010).10.1073/pnas.0913667107 ↗

42. Champion, J. A. & Mitragotri, S. Proc. Natl Acad. Sci. USA 103, 4930–4934 (2006).10.1073/pnas.0600997103 ↗

43. Geng, Y. et al. Nature Nanotech. 2, 249–255 (2007).10.1038/nnano.2007.70 ↗

44. Dellian, M., Yuan, F., Trubetskoy, V. S., Torchilin, V. P. & Jain, R. K. Br. J. Cancer 82, 1513–1518 (2000).10.1054/bjoc.1999.1171 ↗

45. Stylianopoulos, T., Soteriou, K., Fukumura, D. & Jain, R. Ann. Biomed. Eng. 41, 68–77 (2013).10.1007/s10439-012-0630-4 ↗

46. Krasnici, S. et al. Int. J. Cancer 105, 561–567 (2003).10.1002/ijc.11108 ↗

47. Campbell, R. B. et al. Cancer Res. 62, 6831–6836 (2002).

48. Klibanov, A. L., Maruyama, K., Torchilin, V. P. & Huang, L. FEBS Lett. 268, 235–237 (1990).10.1016/0014-5793(90)81016-H ↗

49. Storm, G., Belliot, S. O., Daemen, T. & Lasic, D. D. Adv. Drug Deliver. Rev. 17, 31–48 (1995).10.1016/0169-409X(95)00039-A ↗

50. Rodriguez, P. L. et al. Science 339, 971–975 (2013).10.1126/science.1229568 ↗

51. Verma, S. et al. N. Engl. J. Med. 367, 1783–1791 (2012).10.1056/NEJMoa1209124 ↗

52. Hoffman, A. S. et al. J. Biomed. Mater. Res. 52, 577–586 (2000).10.1002/1097-4636(20001215)52:4<577::AID-JBM1>3.0.CO;2-5 ↗

53. Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R. & Tsourkas, A. Science 338, 903–910 (2012).10.1126/science.1226338 ↗

54. Jain, R. K. Cancer Res. 48, 2641–2658 (1988).

55. Netti, P. A., Roberge, S., Boucher, Y., Baxter, L. T. & Jain, R. K. Microvasc. Res. 52, 27–46 (1996).10.1006/mvre.1996.0041 ↗

56. Chauhan, V. P. et al. Nature Commun. 4, 2516 (2013).10.1038/ncomms3516 ↗

57. Baish, J. W. et al. Proc. Natl Acad. Sci. USA 108, 1799–1803 (2011).10.1073/pnas.1018154108 ↗

58. Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J. & Jain, R. K. Cancer Res. 60, 2497–2503 (2000).

59. Dvorak, H. F. N. Engl. J. Med. 315, 1650–1659 (1986).10.1056/NEJM198612253152606 ↗

60. Chauhan, V. P. et al. Biophys. J. 97, 330–336 (2009).10.1016/j.bpj.2009.03.064 ↗

61. Pluen, A. et al. Proc. Natl Acad. Sci. USA 98, 4628–4633 (2001).10.1073/pnas.081626898 ↗

62. McKee, T. D. et al. Cancer Res. 66, 2509–2513 (2006).10.1158/0008-5472.CAN-05-2242 ↗

63. Weinstein, J. N. & van Osdol, W. Cancer Res. 52, 2747s–2751s (1992).

64. Haun, J. B. & Hammer, D. A. Langmuir 24, 8821–8832 (2008).10.1021/la8005844 ↗

65. Schmidt, M. M. & Wittrup, K. D. Mol. Cancer Ther. 8, 2861–2871 (2009).10.1158/1535-7163.MCT-09-0195 ↗

66. Berk, D. A., Yuan, F., Leunig, M. & Jain, R. K. Proc. Natl Acad. Sci. USA 94, 1785–1790 (1997).10.1073/pnas.94.5.1785 ↗

67. Minchinton, A. I. & Tannock, I. F. Nature Rev. Cancer 6, 583–592 (2006).10.1038/nrc1893 ↗

68. Coley, H. M., Amos, W. B., Twentyman, P. R. & Workman, P. Br. J. Cancer 67, 1316–1323 (1993).10.1038/bjc.1993.244 ↗

69. Lankelma, J. et al. Clin. Cancer Res. 5, 1703–1707 (1999).

70. Smith, N. R. et al. Clin. Cancer Res. http://dx.doi.org/10.1158/1078-0432.CCR-13-1637 (2013).10.1158/1078-0432.CCR-13-1637 ↗

71. Graff, C. P. & Wittrup, K. D. Cancer Res. 63, 1288–1296 (2003).

72. Helmlinger, G., Yuan, F., Dellian, M. & Jain, R. K. Nature Med. 3, 177–182 (1997).10.1038/nm0297-177 ↗

73. Sawant, R. R. & Torchilin, V. P. Soft Matter 6, 4026–4044 (2010).10.1039/b923535n ↗

74. De la Rica, R., Aili, D. & Stevens, M. M. Adv. Drug Deliver. Rev. 64, 967–978 (2012).10.1016/j.addr.2012.01.002 ↗

75. Fleige, E., Quadir, M. A. & Haag, R. Adv. Drug Deliver. Rev. 64, 866–884 (2012).10.1016/j.addr.2012.01.020 ↗

76. Stylianopoulos, T., Wong, C., Bawendi, M. G., Jain, R. K. & Fukumura, D. in Methods in Enzymology — Nanomedicine: Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases Vol. 508 (ed. Duzgunes, N.) 109–130 (Elsevier, 2012).10.1016/B978-0-12-391860-4.00006-9 ↗

77. Sugahara, K. N. et al. Cancer Cell 16, 510–520 (2009).10.1016/j.ccr.2009.10.013 ↗

78. Luo, Y. et al. J. Clin. Invest. 116, 2132–2141 (2006).10.1172/JCI27648 ↗

79. Batchelor, T. T. et al. Proc. Natl Acad. Sci. USA (in the press).

80. Tailor, T. D. et al. Mol. Cancer Ther. 9, 1798–1808 (2010).10.1158/1535-7163.MCT-09-0856 ↗

81. Brown, E. et al. Nature Med. 9, 796–800 (2003).10.1038/nm879 ↗

82. Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y. & Jain, R. K. Proc. Natl Acad. Sci. USA 108, 2909–2914 (2011).10.1073/pnas.1018892108 ↗

83. Stylianopoulos, T. & Jain, R. K. Proc. Natl Acad. Sci. USA (in the press).